Cabergoline

5 trials 1 recruiting GUrology & Gynaecology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

1 Completed trials

5 Sponsors

5 Countries

Phase III

Phase III/IV

Phase IV

Phase III: 2 Phase III/IV: 1 Phase IV: 2

Indications tested

Endometriosis 1 Prolactin-producing pituitary tumour 1

Sponsors using this IMP

Azienda Unita Sanitaria Locale Di Bologna 1 Hospital Clinico San Carlos 1 Region Midtjylland 1 St. Olavs Hospital HF 1 Turku University Central Hospital 1

All trials

5 total

The effect of cabergoline in infertile women on peritoneal endometriosis related dysmenorrhea, chronic pelvic pain and fertility Not authorised

2022-500792-31-00 Phase IV 1 country Turku University Central Hospital
Surgical versus Medical Treatment in Microprolactinomas (SUMET PRO) Pending

2024-516383-28-01 Phase III 1 country Azienda Unita Sanitaria Locale Di Bologna
CARESS Study: Cabergoline for the Reduction of Endometriosis Symptoms and Lesion Size Pending

2025-522812-18-00 Phase III/IV 1 country Hospital Clinico San Carlos
Cabergoline for Episodic Migraine (PROTECT) Recruiting

2025-522323-10-00 Phase III 1 country Region Midtjylland
Dopamine agonist treatment of non-functioning pituitary adenomas (NFPAs) – a randomized controlled trial Ended

2023-510039-12-00 Phase IV 1 country St. Olavs Hospital HF

Showing 1–5 of 5 trials

← All drugs A–Z